Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
160,377,960
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
109,208,822
-
Shares change
-
+18,500,696
-
Total reported value, excl. options
-
$733,878,161
-
Value change
-
+$128,257,287
-
Put/Call ratio
-
51.89%
-
Number of buys
-
95
-
Number of sells
-
-64
-
Price
-
$6.72
Significant Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) as of Q1 2024
186 filings reported holding COGT - Cogent Biosciences, Inc. - Common Stock, $0.001 par value as of Q1 2024.
Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 109,208,822 shares
of 160,377,960 outstanding shares and own 68.09% of the company stock.
Largest 10 shareholders include Kynam Capital Management, LP (8,500,000 shares), STATE STREET CORP (7,626,869 shares), FMR LLC (6,964,608 shares), BlackRock Inc. (6,689,618 shares), Point72 Asset Management, L.P. (6,676,248 shares), COMMODORE CAPITAL LP (6,425,000 shares), TCG Crossover Management, LLC (6,214,375 shares), VANGUARD GROUP INC (5,765,705 shares), VR Adviser, LLC (5,129,167 shares), and Fairmount Funds Management LLC (4,725,641 shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.